Parallel Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$272K Sell
4,246
-3,658
-46% -$240K ﹤0.01% 1085
2026
Q1
$563K Sell
7,904
-287
-4% -$22.6K 0.01% 681
2025
Q4
$672K Buy
8,191
+389
+5% +$30.3K 0.01% 580
2025
Q3
$586K Buy
7,802
+562
+8% +$41.9K 0.01% 603
2025
Q2
$536K Sell
7,240
-307
-4% -$21.4K 0.01% 603
2025
Q1
$609K Buy
7,547
+412
+6% +$35.4K 0.01% 519
2024
Q4
$558K Buy
7,135
+135
+2% +$11.5K 0.01% 560
2024
Q3
$657K Buy
7,000
+583
+9% +$48.9K 0.02% 486
2024
Q2
$500K Sell
6,417
-354
-5% -$28.9K 0.01% 536
2024
Q1
$616K Buy
6,771
+781
+13% +$65K 0.02% 471
2023
Q4
$463K Sell
5,990
-543
-8% -$38K 0.01% 511
2023
Q3
$445K Buy
6,533
+1,714
+36% +$125K 0.01% 489
2023
Q2
$392K Buy
4,819
+832
+21% +$66.4K 0.01% 536
2023
Q1
$327K Buy
+3,987
New +$285K 0.01% 580

Other funds holding GEHC

Parallel Advisors's GEHC Position: Q2 2026 in Review

Parallel Advisors reduced its GE HealthCare (GEHC) stake by 46% in Q2 2026, selling an estimated $240K and leaving 4,246 shares worth $272K. The position accounts for ﹤0.01% of the portfolio, ranked #1085.

Parallel Advisors first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $672K in Q4 2025. 1,227 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Parallel Advisors held 4,246 shares of GE HealthCare worth $272K as of Q2 2026.
  • Parallel Advisors sold 3,658 GE HealthCare shares in Q2 2026, an estimated $240K.
  • GE HealthCare made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #1085 holding.
  • Parallel Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Parallel Advisors's GE HealthCare position peaked at $672K in Q4 2025.
  • 1,227 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.